You are here:Home1/Pathfinder2/News3/Travere Therapeutics Reports First Quarter 2022 Financial Results
Travere Therapeutics Reports First Quarter 2022 Financial Results
SAN DIEGO, Feb. 24, 2022 (GLOBE NEWSWIRE) — Travere Therapeutics, Inc. (NASDAQ: TVTX) reported its first quarter 2022 financial results and provided a corporate update.